# Dr. Reddy’s Laboratories Limited (NYSE: RDY), FTO-11, India – FDA Inspections

Source: https://www.keypedia.com/companies/dr-reddys-laboratories-limited/19f1fec5-d1fb-47f3-92bb-7e3e0f0db5d6

> Inspection records and compliance data for Dr. Reddy’s Laboratories Limited in FTO-11, Survey No 30. 1 FDA inspection on record, 1 Form 483, last inspected July 18, 2025. Publicly traded as NYSE: RDY.

---

## Details

- Name: Dr. Reddy’s Laboratories Limited
- FEI Number: 3012414462
- Address Line 1: Formulations Technical Operations
- City: FTO-11
- State: Survey No 30
- Country Name: India
- Address: Formulations Technical Operations, FTO-11, Survey No 30, India
- Country: India

## Stock

- Stock ticker: RDY
- Exchange: NYSE
- Share price: $14.73
- Market cap: $12.3B
- Price as of: November 13, 2026

## Related Documents

- [483 - Dr. Reddy’s Laboratories Limited - 2025-07-18](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited/8dac255a-f01f-4ca0-b11a-bc115b577414) — source: FDA, date: July 18, 2025
- FDA Inspection 1277412 - Dr. Reddy’s Laboratories Limited - 2025-07-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2025
- [FDA Inspection 1277412 - Dr. Reddy’s Laboratories Limited - 2025-07-18](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-limited/79009aa6-a9bc-49bb-aea5-2ee93c2e5837) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2025
- [483 - Dr. Reddy’s Laboratories Limited - 2022-07-07](https://www.keypedia.com/records/483/dr-reddys-laboratories-limited/da825a57-d71c-458f-b9ea-f8ff1569e3f3) — source: FDA, date: July 7, 2022

## Related Companies

- [Teyro Labs Private Limited](https://www.keypedia.com/companies/teyro-labs-private-limited/8744f9fc-f440-4610-ac34-05b15c46173b)
- [LSNE-Leon, SLU](https://www.keypedia.com/companies/lsne-leon-slu/44b5bd66-624e-4c64-8c14-68139ec58183)
- [Stira Pharmaceuticals LLC](https://www.keypedia.com/companies/stira-pharmaceuticals-llc/5e44f5bb-4d18-40fa-b93c-7510e3099999)
- [FAMAR HEALTH CARE SERVICES MADRID SA](https://www.keypedia.com/companies/famar-health-care-services-madrid-sa/714d760c-6b6d-4a4b-9b1e-998380c3ba18)
- [Shilpa Medicare Limited](https://www.keypedia.com/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655)
- [Biocon Biologics Limited](https://www.keypedia.com/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d)
- [Eugia Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559)
- [Pharmathen International S.A.](https://www.keypedia.com/companies/pharmathen-international-sa/4486b3e5-4ce8-40ff-80da-e4364db37198)
- [Eugia SEZ Private Limited](https://www.keypedia.com/companies/eugia-sez-private-limited/c458dd25-5620-40af-93fe-f25936ff47e8)
- [RK Pharma Inc.](https://www.keypedia.com/companies/rk-pharma-inc/04d6c855-6dac-45ed-8597-0541bddd3bce)

## Related Officers

- [Consumer Safety Officer, Drug Specialist](https://www.keypedia.com/people/taichun-qin/62349336-96d6-4452-9c20-9084204b86bf)
- [Investigator](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)
- [Jigar R. Patel](https://www.keypedia.com/people/jigar-r-patel/db40ddb1-d737-46eb-a94c-3ecaf6a8de9c)
